Wolfe Research analyst Alexandria Hammond initiated coverage of Moderna (MRNA) with an Underperform rating and $40 price target Moderna may ...
Kennedy ran for president in this year's election as an independent before dropping out in August and endorsing Trump in exchange for a role in the Republican's administration ...